
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 218 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Post-marketing surveillance using a computerised general practice data base”, Pharmaceutical Medicine, vol. 2, pp. 345-351, 1988.
, “A comparison of the risk of hypoglycemia between users of human and animal insulins. 1. Experience in the United Kingdom”, Pharmacotherapy, vol. 10, pp. 395-7, 1990.
, “A total audit of preventive procedures in 45 practices caring for 430,000 patients”, Bmj, vol. 300, pp. 1501-3, 1990.
, “Validation of information recorded on general practitioner based computerised data resource in the United Kingdom”, Bmj, vol. 302, pp. 766-8, 1991.
, “Antidepressant drugs and suicide”, J Clin Psychopharmacol, vol. 12, pp. 235-40, 1992.
, “Antidepressants and convulsions”, J Clin Psychopharmacol, vol. 12, pp. 241-5, 1992.
, “Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone”, Pharmacotherapy, vol. 12, pp. 451-4, 1992.
, “Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom”, Pharmacoepidemiology and Drug Safety, vol. 1, pp. 347-349, 1992.
, “Liver disease associated with diclofenac, naproxen, and piroxicam”, Pharmacotherapy, vol. 12, pp. 207-12, 1992.
, “Micturin and torsades de pointe — experience of a post‐marketing alert”, vol. 1, pp. 147 - 150, 1992.
, “NSAIDs, quinolones and convulsions: An epidemiologic approach”, vol. 6, pp. 119-128, 1992.
, “Research implications of computerised primary care”, Post Marketing Surveillance, vol. 5, pp. 259-268, 1992.
, “Urinary tract infections and estrogen use in older women”, J Am Geriatr Soc, vol. 40, pp. 817-20, 1992.
, “Accuracy of diagnosis of psychosis on general practice computer system”, Bmj, vol. 307, pp. 32-4, 1993.
, “Care of schizophrenia in general practice”, Bmj, vol. 307, p. 910, 1993.
, “Cholestatic hepatitis associated with flucloxacillin”, Med J Aust, vol. 158, pp. 596-600, 1993.
, “A concurrent cohort study of oral contraceptive users from the VAMP research bank”, Pharmacoepidemiology and Drug Safety, vol. 2, pp. 51-63, 1993.
, “Erythromycin-associated cholestatic hepatitis”, Med J Aust, vol. 158, pp. 600-2, 1993.
, “A follow-up safety study of ciprofloxacin users”, Pharmacotherapy, vol. 13, pp. 461-4, 1993.
, “Liver disorders in patients receiving chlorpromazine or isoniazid”, Pharmacotherapy, vol. 13, pp. 353-8, 1993.
, “Micturin (Terodiline Hydrochloride), Torsades de Pointe and other Arrhythmias — A Study using the VAMP Database”, Pharmacoepidemiology and Drug Safety, vol. 2, pp. 127-132, 1993.
, “Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study”, Pharmacotherapy, vol. 13, pp. 212-7, 1993.
, “Towards accurate prescribing analysis in general practice: accounting for the effects of practice demography”, Br J Gen Pract, vol. 43, pp. 102-6, 1993.
, “Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors”, Arch Intern Med, vol. 154, pp. 311-6, 1994.
, “Flucloxacillin and cholestatic hepatitis”, Med J Aust, vol. 160, p. 525, 1994.
, “Practice based information systems for monitoring medicines”, Pharmaceutical Medicine, vol. 8, pp. 161-176, 1994.
, “The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions”, Pharmacoepidemiology and Drug Safety, vol. 3, pp. 15-21, 1994.
, “Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs”, Bmj, vol. 308, pp. 503-6, 1994.
, “Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs”, Lancet, vol. 343, pp. 769-72, 1994.
, “A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women”, J Clin Epidemiol, vol. 47, pp. 307-12, 1994.
, “The use of nitrates, calcium channel blockers and ACE inhibitors in primary care in the Northern Region: a pharmacoepidemiological study”, Br J Clin Pharmacol, vol. 38, pp. 489-97, 1994.
, “The VAMP system and the detection of risk, some examples”, Pharmacoepidemiology and Drug Safety, vol. 3, pp. 313-319, 1994.
, “Antidepressants and suicide”, Bmj, vol. 310, pp. 215-8, 1995.
, “Care of schizophrenia in general practice: the general practitioner and the patient”, Br J Gen Pract, vol. 45, pp. 343-7, 1995.
, “Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records”, J Epidemiol Community Health, vol. 49, pp. 389-94, 1995.
, “A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity”, Pharmacotherapy, vol. 15, pp. 428-32, 1995.
, “Ocular safety of antiulcer drugs”, Lancet, vol. 345, pp. 1059-60, 1995.
, “Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components”, Lancet, vol. 346, pp. 1589-93, 1995.
, “The risk of sulfasalazine- and mesalazine-associated blood disorders”, Pharmacotherapy, vol. 15, pp. 176-81, 1995.
, , “A cohort study of the ocular safety of anti-ulcer drugs”, Br J Clin Pharmacol, vol. 42, pp. 213-6, 1996.
, “The demand for eating disorder care. An epidemiological study using the general practice research database”, Br J Psychiatry, vol. 169, pp. 705-12, 1996.
, “Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid”, Arch Intern Med, vol. 156, pp. 1327-32, 1996.
, “The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension”, Pharmacotherapy, vol. 16, pp. 321-6, 1996.
, “Sudden unexplained death among subjects with refractory epilepsy”, Epilepsia, vol. 37, pp. 931-5, 1996.
, “The Use of the General Practice Research Database (Gprd) to Examine Potential Links between Antidepressant Medication and the Incidence of Suicide”, Drug Information Journal, vol. 30, pp. 785-792, 1996.
, , “5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis”, Am J Gastroenterol, vol. 92, pp. 816-20, 1997.
, “Anticonvulsants and congenital malformations”, Pharmacotherapy, vol. 17, pp. 561-4, 1997.
, “Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension”, Epidemiology, vol. 8, pp. 446-8, 1997.
,